Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06647134
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
Sponsor: M.D. Anderson Cancer Center
View on ClinicalTrials.gov
Summary
To understand the severity and nature of participants experiences during irAEs following immune checkpoint inhibitor immunotherapy.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2024-09-11
Completion Date
2028-03-31
Last Updated
2025-10-14
Healthy Volunteers
No
Locations (1)
MD Anderson Cancer Center
Houston, Texas, United States